AI Analysis AI Analysis of ENTA
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Red day on Friday for Enanta Pharmaceuticals
(Updated on Mar 14, 2025)

Buy or Hold candidate since Mar 06, 2025 Loss -7.38%

The Enanta Pharmaceuticals stock price fell by -2.64% on the last day (Friday, 14th Mar 2025) from $6.83 to $6.65. During the last trading day the stock fluctuated 5.87% from a day low at $6.64 to a day high of $7.03. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period. Volume has increased on the last day by 150 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 341 thousand shares were bought and sold for approximately $2.27 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.31 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 32.57% during the next 3 months and, with a 90% probability hold a price between $8.37 and $11.90 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

ENTA Signals & Forecast

A sell signal was issued from a pivot top point on Tuesday, February 25, 2025, and so far it has fallen -21.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Enanta Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $7.02. On a fall, the stock will find some support from the long-term average at approximately $6.60. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.85 and $5.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enanta Pharmaceuticals finds support just below today's level at $5.85. If this is broken, then the next support from accumulated volume will be at $5.75 and $5.59.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.390 between high and low, or 5.87%. For the last week, the stock has had daily average volatility of 9.08%.

Enanta Pharmaceuticals is oversold on RSI14 (24). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $6.28 (-5.52%) (This stock has high daily movements and this gives high risk. Low RSI14 is 24 which reduces the risk some. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect Enanta Pharmaceuticals to open at $6.77, and during the day (based on 14 day Average True Range), to move between $6.11 and $7.19, which gives a possible trading interval of +/-$0.543 (+/-8.17%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 16.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.85 (12.03%) than the resistance at $7.50 (12.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enanta Pharmaceuticals stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 1.809 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on March 17, 2025 - $6.77 ( 1.85%).

ENTA Performance

Trading levels for ENTA

Fibonacci Support & Resistance Levels

Level Price
R3 7.16 7.72%
R2 7.01 5.48%
R1 6.92 4.09%
Price 6.65
S1 6.62 -0.386%
S2 6.53 -1.77%
S3 6.38 -4.01%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.30 24.81%
R2 8.03 20.75%
R1 7.50 12.78%
Price 6.65
S1 5.85 -12.03%
S2 5.75 -13.53%
S3 5.59 -15.94%

FAQ

What is the symbol for Enanta Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enanta Pharmaceuticals is ENTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Enanta Pharmaceuticals Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

How to buy Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.

What's the current price of Enanta Pharmaceuticals Stock?
As of the end of day on the Mar 14, 2025, the price of an Enanta Pharmaceuticals (ENTA) share was $6.65.

What is the 52-week high and low for Enanta Pharmaceuticals Stock?
The 52-week high for Enanta Pharmaceuticals Stock is $17.80 and the 52-week low is $4.71.

What is the market capitalization of Enanta Pharmaceuticals Stock?
As of the Mar 14, 2025, the market capitalization of Enanta Pharmaceuticals is 141.861M.

When is the next earnings date for Enanta Pharmaceuticals?
The upcoming earnings date for Enanta Pharmaceuticals is May 05, 2025.
Click to get the best stock tips daily for free!
ABOUT ENANTA PHARMACEUTICALS
Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro...
GOLDEN STAR
Ticker Change Signal Date
ALE
$65.32
0.490% Mar 12
AMED
$92.12
0.488% Mar 12
HESM
$40.63
3.59% Mar 11
HDB
$59.97
1.18% Feb 26
ML
$86.18
0.139% Feb 26

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE